Affimed NV Company Insiders
AFMD Stock | USD 2.84 0.03 1.05% |
Affimed NV employs about 76 people. The company is managed by 12 executives with a total tenure of roughly 19 years, averaging almost 1.0 years of service per executive, having 6.33 employees per reported executive. Evaluation of Affimed NV's management performance can provide insight into the firm performance.
Adi Hoess CEO CEO, Member of the Management Board |
Affimed |
Affimed NV's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Affimed NV's future performance. Based on our forecasts, it is anticipated that Affimed will maintain a workforce of about 200000 employees by December 2024.Affimed NV Management Team Effectiveness
The company has return on total asset (ROA) of (0.4931) % which means that it has lost $0.4931 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2408) %, meaning that it created substantial loss on money invested by shareholders. Affimed NV's management efficiency ratios could be used to measure how well Affimed NV manages its routine affairs as well as how well it operates its assets and liabilities. As of November 29, 2024, Return On Tangible Assets is expected to decline to -1.15. The current year's Return On Capital Employed is expected to grow to -1.42. At present, Affimed NV's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 162.2 M, whereas Intangible Assets are forecasted to decline to about 23.8 K.The current year's Common Stock Shares Outstanding is expected to grow to about 15.7 M, whereas Net Loss is projected to grow to (49.2 M).
Affimed NV Workforce Comparison
Affimed NV is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,957. Affimed NV holds roughly 76.0 in number of employees claiming about 4% of equities under Health Care industry.
Affimed NV Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Affimed NV Price Series Summation is a cross summation of Affimed NV price series and its benchmark/peer.
Affimed NV Notable Stakeholders
An Affimed NV stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Affimed NV often face trade-offs trying to please all of them. Affimed NV's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Affimed NV's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Adi Hoess | CEO, Member of the Management Board | Profile | |
Wolfgang Fischer | COO, Member of the Management Board | Profile | |
Uwe Reusch | Head Culture | Profile | |
Denise Mueller | Chief Board | Profile | |
RPh PharmD | Chief Officer | Profile | |
Arndt MD | Chief Board | Profile | |
Angus Smith | CFO Board | Profile | |
Michael Wolf | Head Administration | Profile | |
Andreas MD | Chief Board | Profile | |
Mary Sandin | Vice Communications | Profile | |
Pr Little | Founder Consultant | Profile | |
Alexander Fudukidis | Head Relations | Profile |
About Affimed NV Management Performance
The success or failure of an entity such as Affimed NV often depends on how effective the management is. Affimed NV management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Affimed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Affimed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.09) | (1.15) | |
Return On Capital Employed | (1.50) | (1.42) | |
Return On Assets | (1.09) | (1.14) | |
Return On Equity | (1.83) | (1.74) |
Please note, the presentation of Affimed NV's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Affimed NV's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Affimed NV's management manipulating its earnings.
Affimed NV Workforce Analysis
Traditionally, organizations such as Affimed NV use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Affimed NV within its industry.Affimed NV Manpower Efficiency
Return on Affimed NV Manpower
Revenue Per Employee | 108.9K | |
Revenue Per Executive | 689.6K | |
Net Loss Per Employee | 1.4M | |
Net Loss Per Executive | 8.8M | |
Working Capital Per Employee | 766.9K | |
Working Capital Per Executive | 4.9M |
Complementary Tools for Affimed Stock analysis
When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |